Analystreport

Health Catalyst, Inc. (NASDAQ: HCAT) is now covered by analysts at BTIG Research. They set a "buy" rating and a $60.00 price target on the stock.

Health Catalyst, Inc - Common stock  (HCAT) 
Last health catalyst, inc - common stock earnings: 2/27 04:05 pm Check Earnings Report